Literature DB >> 25971839

In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.

Chinatsu Shimafuji1, Megumi Noguchi2, Mami Nishie3, Jun-Ichi Nagao4, Kouki Shioya5, Takeshi Zendo6, Jiro Nakayama7, Kenji Sonomoto8.   

Abstract

Lantibiotics are antibacterial peptides containing unique thioether cross-links termed lanthionine and methyllanthionine. NukM, the modifying enzyme of nukacin ISK-1, which is produced by Staphylococcus warneri ISK-1, catalyzes the dehydration of specific Ser/Thr residues in a precursor peptide, followed by conjugative addition of intramolecular Cys to dehydrated residues to generate a cyclic structure. By contrast, the precursor peptide of nisin is modified by 2 enzymes, NisB and NisC, which mediate dehydration and cyclization, respectively. While the C-terminal domain of NukM is homologous to NisC, the N-terminal domain has no homology with other known proteins. We expressed and characterized the N- and C-terminal domains of NukM, NukMN, and NukMC, separately. In vitro reconstitution revealed that full-length NukM fully modified the substrate peptide NukA. NukMN partially phosphorylated, dehydrated, and cyclized NukA. By contrast, NukMC did not catalyze dehydration, phosphorylation, or cyclization reactions. Interaction studies using surface plasmon resonance analysis indicated that NukM and NukMN can bind NukA with high affinity, whereas NukMC has low substrate-recognition activity. These results suggest that NukMN is mainly responsible for substrate recognition and dehydration and that the whole NukM structure, including the C-terminal domain, is required for the complete modification of NukA. To the best of our knowledge, this is the first report providing insights into the in vitro catalytic activity of individual domains of a LanM-type modification enzyme.
Copyright © 2015 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lantibiotic; Modification enzyme; Nukacin ISK-1; Peptide engineering; Unusual amino acids

Mesh:

Substances:

Year:  2015        PMID: 25971839     DOI: 10.1016/j.jbiosc.2015.03.020

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  5 in total

Review 1.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

2.  Substrate Recognition by the Class II Lanthipeptide Synthetase HalM2.

Authors:  Imran R Rahman; Jeella Z Acedo; Xiaoran Roger Liu; Lingyang Zhu; Justine Arrington; Michael L Gross; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2020-04-28       Impact factor: 5.100

Review 3.  Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.

Authors:  Anton Du Preez van Staden; Winschau F van Zyl; Marla Trindade; Leon M T Dicks; Carine Smith
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

4.  Bioprocess Development for Lantibiotic Ruminococcin-A Production in Escherichia coli and Kinetic Insights Into LanM Enzymes Catalysis.

Authors:  Elvis L Ongey; Lara Santolin; Saskia Waldburger; Lorenz Adrian; Sebastian L Riedel; Peter Neubauer
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

5.  The enterococcal cytolysin synthetase has an unanticipated lipid kinase fold.

Authors:  Shi-Hui Dong; Weixin Tang; Tiit Lukk; Yi Yu; Satish K Nair; Wilfred A van der Donk
Journal:  Elife       Date:  2015-07-30       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.